The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
The meeting of the Russian Council of Experts for the use of the novel anabolic agent Forsteo®(teriparatide) to treat osteoporosis (OP) was held in Moscow on June 29, 2013. The meeting was attended by leading Russian OP specialists, including the members of the Russian Osteoporosis Association and i...
Saved in:
| Main Author: | Olga Mikhailovna Lesnyak |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2013-10-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/502 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022-04-01) -
Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects
by: Harsh Durgia, et al.
Published: (2025-01-01) -
Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01) -
Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trial
by: Huan Wang, et al.
Published: (2025-07-01) -
Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
by: Liangshi Chen, et al.
Published: (2025-04-01)